Haw Par Corporation Limited

SGX:H02.SI

10.31 (SGD) • At close July 18, 2024
Bedrijfsnaam Haw Par Corporation Limited
Symbool H02.SI
Munteenheid SGD
Prijs 10.32
Beurswaarde 2,284,517,760
Dividendpercentage 4.12%
52-weken bereik 9.19 - 10.49
Industrie Drug Manufacturers—General
Sector Healthcare
CEO Mr. Ee Lim Wee
Website https://www.hawpar.com

An error occurred while fetching data.

Over Haw Par Corporation Limited

Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan

Vergelijkbare Aandelen

Summerset Group Holdings Limited logo

Summerset Group Holdings Limited

SUM.NZ

9.72 NZD

Centro de Imagem Diagnósticos S.A. logo

Centro de Imagem Diagnósticos S.A.

AALR3.SA

12.41 BRL

Kora Saúde Participações S.A. logo

Kora Saúde Participações S.A.

KRSA3.SA

0.71 BRL

Ramsay Générale de Santé SA logo

Ramsay Générale de Santé SA

GDS.PA

15.6 EUR

Raffles Medical Group Ltd logo

Raffles Medical Group Ltd

BSL.SI

1.03 SGD

Empreendimentos Pague Menos S.A. logo

Empreendimentos Pague Menos S.A.

PGMN3.SA

2.82 BRL

Oncoclínicas do Brasil Serviços Médicos S.A. logo

Oncoclínicas do Brasil Serviços Médicos S.A.

ONCO3.SA

7.04 BRL

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited logo

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

T14.SI

1.87 USD

Financiële Gegevens

Cijfers zijn in miljoenen (SGD)

Cijfers zijn in miljoenen (SGD)